Publications by authors named "Naoki Cho"

Claim this Profile
P
Pharmacokinetic Bioequivalence, Safety, and Immunogenicity of DMB-3115, an Ustekinumab Biosimilar, and EU- and US-Stelara in Healthy Adult Participants: A Randomized, Double-Blind, Single-Dose Study.
Jun Morita, Rainard Fuhr, Thomas Koernicke, Naoki Cho, Thin Thin Mencarini

Adv Ther· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, Tolerability, and Pharmacokinetics of a Novel Oral Phosphodiesterase 4 Inhibitor, ME3183: First-in-Human Phase 1 Study.
Seiji Kato, Naoki Cho, Tomokazu Koresawa, Kazunari Otake, Akiko Kano

Clin Pharmacol Drug Dev· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
ME3183, a novel phosphodiesterase-4 inhibitor, exhibits potent anti-inflammatory effects and is well tolerated in a non-clinical study.
Natsuki Kubota-Ishida, Chizuko Kaji, Shogo Matsumoto, Tsubasa Wakabayashi, Takashi Matsuhira, Naoki Cho

Eur J Pharmacol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Formation of reactive metabolites of benzbromarone in humanized-liver mice.
Naoki Cho, Hiroshi Suemizu, Hidetaka Kamimura, Tomoyuki Ohe, Fumi Ito

Drug Metab Pharmacokinet· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selection of the candidate compound at an early stage of new drug development: retrospective pharmacokinetic and metabolic evaluations of valsartan using common marmosets.
Shogo Matsumoto, Shotaro Uehara, Hidetaka Kamimura, Naoki Cho, Hiroshi Ikeda

Xenobiotica· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Empirical and theoretical approaches for the prediction of human hepatic clearance using chimeric mice with humanised liver: the use of physiologically based scaling, a novel solution for potential overprediction due to coexisting mouse metabolism.
Shogo Matsumoto, Hidetaka Kamimura, Megumi Nishiwaki, Naoki Cho, Kazuhiko Kato

Xenobiotica· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of a reactive intermediate derived from 1',6-dihydroxy metabolite with benzbromarone-induced hepatotoxicity.
Mina Yoshida, Naoki Cho, Hidetaka Akita, Kaoru Kobayashi

J Biochem Mol Toxicol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of novel glutathione adducts of benzbromarone in human liver microsomes.
Naoki Cho, Kaoru Kobayashi, Mina Yoshida, Noriyuki Kogure, Hiromitsu Takayama

Drug Metab Pharmacokinet· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis